Catalyst Biosciences Provides DalcA Phase 2b Trial Update

http://ir.catalystbiosciences.com/news-releases/news-release-details/catalyst-biosciences-provides-dalca-phase-2b-trial-update
JOIN OUR MAILING LIST

 

 
 
 
 

IPIRA is committed to meeting the needs of people with disabilities in a timely manner by preventing and removing barriers to accessibility. We also adhere to the UC Berkeley policy on nondiscrimination, and protect the privacy of confidential information.